• Consensus Rating: Hold
  • Consensus Price Target: $6.67
  • Forecasted Upside: 177.78%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$2.40
▲ +0.03 (1.27%)
Get New (ANTX) Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ANTX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ANTX

Analyst Price Target is $6.67
▲ +177.78% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for (ANTX) in the last 3 months. The average price target is $6.67, with a high forecast of $7.00 and a low forecast of $6.00. The average price target represents a 177.78% upside from the last price of $2.40.

This chart shows the closing price for ANTX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 4 investment analysts is to hold stock in (ANTX). This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
11/2/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/31/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
5/1/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
7/30/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
10/28/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/26/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
3/26/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/25/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/2/2024JMP SecuritiesUpgradeMarket Perform ➝ Outperform$6.00N/A
4/1/2024OppenheimerReiterated RatingMarket Perform ➝ Market PerformN/A
2/13/2024SVB LeerinkDowngradeOutperform ➝ Market Perform$23.00 ➝ $7.00N/A
2/12/2024Evercore ISIDowngradeOutperform ➝ In-Line$25.00 ➝ $7.00N/A
2/12/2024OppenheimerDowngradeOutperform ➝ Market PerformN/A
2/12/2024JMP SecuritiesDowngradeOutperform ➝ Market PerformN/A
1/4/2024JMP SecuritiesInitiated CoverageOutperform$30.00N/A
3/30/2023OppenheimerBoost TargetOutperform$20.00 ➝ $24.00N/A
11/14/2022SVB LeerinkLower TargetOutperform$27.00 ➝ $25.00N/A
4/19/2022SVB LeerinkReiterated RatingOutperformN/A
4/19/2022OppenheimerInitiated CoverageOutperform$22.00N/A
4/19/2022Evercore ISIInitiated CoverageOutperform$25.00N/A
4/19/2022CowenInitiated CoverageOutperformN/A
4/19/2022CowenInitiated CoverageOutperformN/A
6/25/2019Royal Bank of CanadaReiterated RatingOutperform$29.00 ➝ $31.00N/A
5/2/2019OppenheimerInitiated CoverageOutperform$20.00Low
(Data available from 4/25/2019 forward)

News Sentiment Rating

0.26 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/28/2023
  • 3 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/28/2023
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/27/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/27/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/26/2024
  • 0 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/25/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/26/2024
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/25/2024

Current Sentiment

  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
(ANTX) logo
Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2017, it served 40.2 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Read More

Today's Range

Now: $2.40
Low: $2.39
High: $2.44

50 Day Range

MA: N/A

52 Week Range

Now: $2.40
Low: $47.02
High: $64.78

Volume

44,726 shs

Average Volume

345,171 shs

Market Capitalization

$71.45 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of (ANTX)?

The following sell-side analysts have issued stock ratings on (ANTX) in the last twelve months: Evercore ISI, JMP Securities, Oppenheimer Holdings Inc., StockNews.com, and SVB Leerink LLC.
View the latest analyst ratings for ANTX.

What is the current price target for (ANTX)?

3 Wall Street analysts have set twelve-month price targets for (ANTX) in the last year. Their average twelve-month price target is $6.67, suggesting a possible upside of 177.8%. Evercore ISI has the highest price target set, predicting ANTX will reach $7.00 in the next twelve months. JMP Securities has the lowest price target set, forecasting a price of $6.00 for (ANTX) in the next year.
View the latest price targets for ANTX.

What is the current consensus analyst rating for (ANTX)?

(ANTX) currently has 3 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ANTX, but not buy more shares or sell existing shares.
View the latest ratings for ANTX.

What other companies compete with (ANTX)?

How do I contact (ANTX)'s investor relations team?

The company's listed phone number is 650-331-9090 and its investor relations email address is [email protected]. The official website for (ANTX) is www.antheminc.com. Learn More about contacing (ANTX) investor relations.